The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US8637528, OM69 ID: ALA3924897
PubChem CID: 91808732
Max Phase: Preclinical
Molecular Formula: C20H25N4O2+
Molecular Weight: 353.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(N)ccc1-c1cc2c(c(=O)[nH]1)C(C1CCCCC1)N=[N+]2C
Standard InChI: InChI=1S/C20H24N4O2/c1-24-16-11-15(14-9-8-13(21)10-17(14)26-2)22-20(25)18(16)19(23-24)12-6-4-3-5-7-12/h8-12,19H,3-7H2,1-2H3,(H2-,21,22,25)/p+1
Standard InChI Key: MEQLCCSBIKIYJU-UHFFFAOYSA-O
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
4.9456 1.3452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9046 0.7483 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8991 -0.7525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1969 -1.5045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1945 -3.0045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2328 -3.6062 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8943 -3.7525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5965 -3.0004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5987 -1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4133 1.7530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8032 3.1233 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3115 2.9665 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4916 3.8582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8813 1.4408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4481 0.0574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.9346 -0.1433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.8516 1.0438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2821 2.4315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7956 2.6321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3383 -1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
5 7 2 0
7 8 1 0
8 9 2 0
9 3 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 1 0
15 16 2 0
16 12 1 0
16 17 1 0
14 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 18 1 0
13 24 1 0
24 25 2 0
24 26 1 0
26 10 1 0
M CHG 1 16 1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 353.45Molecular Weight (Monoisotopic): 353.1972AlogP: 3.99#Rotatable Bonds: 3Polar Surface Area: 83.48Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.46CX Basic pKa: 3.74CX LogP: -1.27CX LogD: -1.04Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.65Np Likeness Score: 0.09
References 1. (2014) Use of PDE7 inhibitors for the treatment of movement disorders,